These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36507985)

  • 1. Noninvasive Quantitative PET Imaging in Humans of the Pancreatic Beta-Cell Mass Biomarkers VMAT2 and Dopamine D2/D3 Receptors In Vivo.
    Bini J; Carson RE; Cline GW
    Methods Mol Biol; 2023; 2592():61-74. PubMed ID: 36507985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET Imaging of Pancreatic Dopamine D
    Bini J; Sanchez-Rangel E; Gallezot JD; Naganawa M; Nabulsi N; Lim K; Najafzadeh S; Shirali A; Ropchan J; Matuskey D; Huang Y; Herold KC; Harris PE; Sherwin RS; Carson RE; Cline GW
    J Nucl Med; 2020 Apr; 61(4):570-576. PubMed ID: 31601695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-sectional and Test-Retest Characterization of PET with [(18)F]FP-(+)-DTBZ for β Cell Mass Estimates in Diabetes.
    Freeby MJ; Kringas P; Goland RS; Leibel RL; Maffei A; Divgi C; Ichise M; Harris PE
    Mol Imaging Biol; 2016 Apr; 18(2):292-301. PubMed ID: 26370678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo imaging of beta-cell mass in rats using 18F-FP-(+)-DTBZ: a potential PET ligand for studying diabetes mellitus.
    Kung MP; Hou C; Lieberman BP; Oya S; Ponde DE; Blankemeyer E; Skovronsky D; Kilbourn MR; Kung HF
    J Nucl Med; 2008 Jul; 49(7):1171-6. PubMed ID: 18552132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine D1, D2, D3 receptors, vesicular monoamine transporter type-2 (VMAT2) and dopamine transporter (DAT) densities in aged human brain.
    Sun J; Xu J; Cairns NJ; Perlmutter JS; Mach RH
    PLoS One; 2012; 7(11):e49483. PubMed ID: 23185343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET quantification of pancreatic VMAT 2 binding using (+) and (-) enantiomers of [¹⁸F]FP-DTBZ in baboons.
    Harris PE; Farwell MD; Ichise M
    Nucl Med Biol; 2013 Jan; 40(1):60-4. PubMed ID: 23102539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased VMAT2 in the pancreas of humans with type 2 diabetes mellitus measured in vivo by PET imaging.
    Cline GW; Naganawa M; Chen L; Chidsey K; Carvajal-Gonzalez S; Pawlak S; Rossulek M; Zhang Y; Bini J; McCarthy TJ; Carson RE; Calle RA
    Diabetologia; 2018 Dec; 61(12):2598-2607. PubMed ID: 29721633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal noninvasive PET-based beta cell mass estimates in a spontaneous diabetes rat model.
    Souza F; Simpson N; Raffo A; Saxena C; Maffei A; Hardy M; Kilbourn M; Goland R; Leibel R; Mann JJ; Van Heertum R; Harris PE
    J Clin Invest; 2006 Jun; 116(6):1506-13. PubMed ID: 16710474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deuterated
    Liu F; Choi SR; Zha Z; Ploessl K; Zhu L; Kung HF
    Nucl Med Biol; 2018 Feb; 57():42-49. PubMed ID: 29306111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of PET Brain Radioligands for Imaging Pancreatic β-Cell Mass: Potential Utility of
    Bini J; Naganawa M; Nabulsi N; Huang Y; Ropchan J; Lim K; Najafzadeh S; Herold KC; Cline GW; Carson RE
    J Nucl Med; 2018 Aug; 59(8):1249-1254. PubMed ID: 29371405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in the development of dopamine D2- and D3-selective radiotracers for PET imaging studies.
    Mach RH; Luedtke RR
    J Labelled Comp Radiopharm; 2018 Mar; 61(3):291-298. PubMed ID: 28857231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo imaging of vesicular monoamine transporter 2 in pancreas using an (18)F epoxide derivative of tetrabenazine.
    Kung HF; Lieberman BP; Zhuang ZP; Oya S; Kung MP; Choi SR; Poessl K; Blankemeyer E; Hou C; Skovronsky D; Kilbourn M
    Nucl Med Biol; 2008 Nov; 35(8):825-37. PubMed ID: 19026944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of pancreatic VMAT2 binding with active and inactive enantiomers of
    Naganawa M; Lin SF; Lim K; Labaree D; Ropchan J; Harris P; Huang Y; Ichise M; Carson RE; Cline GW
    Nucl Med Biol; 2016 Dec; 43(12):743-751. PubMed ID: 27673755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selectivity of probes for PET imaging of dopamine D3 receptors.
    Doot RK; Dubroff JG; Labban KJ; Mach RH
    Neurosci Lett; 2019 Jan; 691():18-25. PubMed ID: 29518538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoroalkyl derivatives of dihydrotetrabenazine as positron emission tomography imaging agents targeting vesicular monoamine transporters.
    Goswami R; Ponde DE; Kung MP; Hou C; Kilbourn MR; Kung HF
    Nucl Med Biol; 2006 Aug; 33(6):685-94. PubMed ID: 16934687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar striatal D2/D3 dopamine receptor availability in adults with Tourette syndrome compared with healthy controls: A [(11) C]-(+)-PHNO and [(11) C]raclopride positron emission tomography imaging study.
    Abi-Jaoude E; Segura B; Obeso I; Cho SS; Houle S; Lang AE; Rusjan P; Sandor P; Strafella AP
    Hum Brain Mapp; 2015 Jul; 36(7):2592-601. PubMed ID: 25788222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker?
    Boileau I; Rusjan P; Houle S; Wilkins D; Tong J; Selby P; Guttman M; Saint-Cyr JA; Wilson AA; Kish SJ
    J Neurosci; 2008 Sep; 28(39):9850-6. PubMed ID: 18815269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET Imaging of Vesicular Monoamine Transporter 2 in Early Diabetic Retinopathy Using [
    Li J; Chen P; Bao Y; Sun Y; He J; Liu X
    Mol Imaging Biol; 2020 Oct; 22(5):1161-1169. PubMed ID: 31650482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of optically resolved 9-fluoropropyl-dihydrotetrabenazine as a potential PET imaging agent targeting vesicular monoamine transporters.
    Kung MP; Hou C; Goswami R; Ponde DE; Kilbourn MR; Kung HF
    Nucl Med Biol; 2007 Apr; 34(3):239-46. PubMed ID: 17383573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Pancreatic VMAT2 Binding with Active and Inactive Enantiomers of [
    Naganawa M; Lim K; Nabulsi NB; Lin SF; Labaree D; Ropchan J; Herold KC; Huang Y; Harris P; Ichise M; Cline GW; Carson RE
    Mol Imaging Biol; 2018 Oct; 20(5):835-845. PubMed ID: 29468404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.